These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 7682709)

  • 1. Targeted delivery of peptide epitopes to class I major histocompatibility molecules by a modified Pseudomonas exotoxin.
    Donnelly JJ; Ulmer JB; Hawe LA; Friedman A; Shi XP; Leander KR; Shiver JW; Oliff AI; Martinez D; Montgomery D
    Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3530-4. PubMed ID: 7682709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presentation of an exogenous antigen by major histocompatibility complex class I molecules.
    Ulmer JB; Donnelly JJ; Liu MA
    Eur J Immunol; 1994 Jul; 24(7):1590-6. PubMed ID: 8026520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pseudomonas exotoxin-mediated delivery of exogenous antigens to MHC class I and class II processing pathways.
    Lippolis JD; Denis-Mize KS; Brinckerhoff LH; Slingluff CL; Galloway DR; Engelhard VH
    Cell Immunol; 2000 Aug; 203(2):75-83. PubMed ID: 11006005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptide-specific killing of antigen-presenting cells by a recombinant antibody-toxin fusion protein targeted to major histocompatibility complex/peptide class I complexes with T cell receptor-like specificity.
    Reiter Y; Di Carlo A; Fugger L; Engberg J; Pastan I
    Proc Natl Acad Sci U S A; 1997 Apr; 94(9):4631-6. PubMed ID: 9114042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploiting retrograde transport of Shiga-like toxin 1 for the delivery of exogenous antigens into the MHC class I presentation pathway.
    Noakes KL; Teisserenc HT; Lord JM; Dunbar PR; Cerundolo V; Roberts LM
    FEBS Lett; 1999 Jun; 453(1-2):95-9. PubMed ID: 10403383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD8+ T-cell mediated tumor protection by Pseudomonas exotoxin fused to ovalbumin in C57BL/6 mice.
    Becerra JC; Arthur JF; Landucci GR; Forthal DN; Theuer CP
    Surgery; 2003 Apr; 133(4):404-10. PubMed ID: 12717358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer immunotherapy using a DNA vaccine encoding the translocation domain of a bacterial toxin linked to a tumor antigen.
    Hung CF; Cheng WF; Hsu KF; Chai CY; He L; Ling M; Wu TC
    Cancer Res; 2001 May; 61(9):3698-703. PubMed ID: 11325841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fusion protein vaccine by domains of bacterial exotoxin linked with a tumor antigen generates potent immunologic responses and antitumor effects.
    Liao CW; Chen CA; Lee CN; Su YN; Chang MC; Syu MH; Hsieh CY; Cheng WF
    Cancer Res; 2005 Oct; 65(19):9089-98. PubMed ID: 16204084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three different MHC class I molecules bind the same CTL epitope of the influenza virus in a primate species with limited MHC class I diversity.
    Evans DT; Knapp LA; Jing P; Piekarczyk MS; Hinshaw VS; Watkins DI
    J Immunol; 1999 Apr; 162(7):3970-7. PubMed ID: 10201917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Construction, expression and immunogenicity analysis of a fusion protein containing M2e of influenza A virus fused to a modified Pseudomonas aeruginosa exotoxin A].
    Xu Y; Yao LH; Chen AJ; Guo JQ; Liu XY; Bo H; Liu LQ; Shu YL; Zhang ZQ
    Bing Du Xue Bao; 2010 May; 26(3):189-94. PubMed ID: 20572339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of epitopes on a mutant form of Pseudomonas exotoxin using serum from humans treated with Pseudomonas exotoxin containing immunotoxins.
    Roscoe DM; Pai LH; Pastan I
    Eur J Immunol; 1997 Jun; 27(6):1459-68. PubMed ID: 9209499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pseudomonas exotoxin contains a specific sequence at the carboxyl terminus that is required for cytotoxicity.
    Chaudhary VK; Jinno Y; FitzGerald D; Pastan I
    Proc Natl Acad Sci U S A; 1990 Jan; 87(1):308-12. PubMed ID: 2104981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recognition of vaccinia virus-encoded major histocompatibility complex class I antigens by virus immune cytotoxic T cells is independent of the polymorphism of the peptide transporters.
    Lobigs M; Müllbacher A
    Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2676-80. PubMed ID: 8464875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invariant chains with the class II binding site replaced by a sequence from influenza virus matrix protein constrain low-affinity sequences to MHC II presentation.
    Carstens C; Newman DK; Bohlen H; König A; Koch N
    Int Immunol; 2000 Nov; 12(11):1561-8. PubMed ID: 11058576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of cytolytic T lymphocytes directed towards the V3 loop of the human immunodeficiency virus type 1 external glycoprotein gp120 by p55gag/V3 chimeric vaccinia viruses.
    Wagner R; Böltz T; Deml L; Modrow S; Wolf H
    J Gen Virol; 1993 Jul; 74 ( Pt 7)():1261-9. PubMed ID: 7687647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presentation and binding affinity of equine infectious anemia virus CTL envelope and matrix protein epitopes by an expressed equine classical MHC class I molecule.
    McGuire TC; Leib SR; Mealey RH; Fraser DG; Prieur DJ
    J Immunol; 2003 Aug; 171(4):1984-93. PubMed ID: 12902502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular delivery of a cytolytic T-lymphocyte epitope peptide by pertussis toxin to major histocompatibility complex class I without involvement of the cytosolic class I antigen processing pathway.
    Carbonetti NH; Irish TJ; Chen CH; O'Connell CB; Hadley GA; McNamara U; Tuskan RG; Lewis GK
    Infect Immun; 1999 Feb; 67(2):602-7. PubMed ID: 9916065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A recombinant form of Pseudomonas exotoxin directed at the epidermal growth factor receptor that is cytotoxic without requiring proteolytic processing.
    Theuer CP; FitzGerald D; Pastan I
    J Biol Chem; 1992 Aug; 267(24):16872-7. PubMed ID: 1512230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delivery of a viral antigen to the class I processing and presentation pathway by Listeria monocytogenes.
    Ikonomidis G; Paterson Y; Kos FJ; Portnoy DA
    J Exp Med; 1994 Dec; 180(6):2209-18. PubMed ID: 7964496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of DNA delivery system using Pseudomonas exotoxin A and a DNA binding region of human DNA topoisomerase I.
    Chen TY; Hsu CT; Chang KH; Ting CY; Whang-Peng J; Hui CF; Hwang J
    Appl Microbiol Biotechnol; 2000 May; 53(5):558-67. PubMed ID: 10855716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.